Prognostic impact of extramedullary plasmacytomas in multiple myeloma.

被引：0
|
作者：
Mattei, D
Grasso, M
Poggi, A
Graziani, F
Gallamini, A
机构：
[1] S Croce Hosp, Cuneo, Italy
[2] Univ Naples 2, Naples, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4943
引用
收藏
页码：278B / 279B
页数：2
相关论文
共 50 条
  • [41] Clinical impact of FISH analysis in extramedullary plasmacytomas
    Jung, H. A.
    Maeng, C. H.
    Jang, J. H.
    Jung, C. W.
    Kim, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] CD200 is a new prognostic factor in multiple myeloma.
    Moreaux, Jerome
    Hose, Dirk
    Reme, Thierry X.
    Jourdan, Eric
    Hundemer, Michael
    Eric, Legouffe
    Moine, Philippe
    Bourin, Philippe
    Moos, Marion
    Corre, Jill
    Mölher, Thomas
    DeVos, John
    Rossi, Jean-Francois
    Goldschmidt, Hartmut
    Klein, Bernard
    BLOOD, 2006, 108 (11) : 338B - 338B
  • [43] The lung resistance protein is an independent prognostic factor in multiple myeloma.
    Pirker, R
    Filipits, M
    Königsberg, R
    Ackermann, J
    Kittler, H
    Pohl, G
    Gisslinger, H
    Huber, H
    Ludwig, H
    Drach, J
    BLOOD, 1999, 94 (10) : 540A - 540A
  • [44] Prognostic influence of the type of graft in allogeneic transplantation for multiple myeloma.
    Gahrton, G
    Svensson, H
    Cavo, M
    Apperley, J
    Bacigalupo, A
    Björkstrand, B
    Bladé, J
    de Laurenzi, A
    de Vries, T
    Ljungman, P
    Michallet, M
    Reiffers, J
    Russell, NH
    Samson, D
    Schaefer, UW
    Schattenberg, A
    Thierry, F
    Verdonck, LF
    Vernant, JP
    Volin, L
    BONE MARROW TRANSPLANTATION, 1999, 23 : S134 - S134
  • [45] Soluble syndecan-1 is a prognostic marker in multiple myeloma.
    Jánosi, J
    Sebestyén, A
    Mikala, G
    Petö, M
    Jákó, J
    Domján, G
    Németh, R
    Kiss, Z
    Kopper, L
    Vályi-Nagy, I
    BLOOD, 2003, 102 (11) : 362B - 362B
  • [46] Prognostic value of serum lactate dehydrogenase in symptomatic multiple myeloma.
    Patel, Krina K.
    Orlowski, Robert Z.
    Weber, Donna M.
    Wang, Michael
    Thomas, Sheeba K.
    Shah, Jatin J.
    Turturro, Francesco
    Alexanian, Raymond
    Delasalle, Kay
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Advanced age is not an adverse prognostic factor for patients with multiple myeloma.
    Dimopoulos, M
    Pouli, A
    Zervas, K
    Gika, D
    Repousis, P
    Mitsouli, C
    Grigoraki, V
    Anagnostopoulos, N
    Stamatellou, M
    Symeonidis, A
    Maniatis, A
    BLOOD, 2002, 100 (11) : 600A - 600A
  • [48] IgA multiple myeloma with multiple cutaneous plasmacytomas
    García-Malo, MD
    Vallejo, C
    Vicente, V
    HAEMATOLOGICA, 2001, 86 (10) : 1118 - 1118
  • [49] Extramedullary multiple myeloma
    Bhutani, Manisha
    Foureau, David M.
    Atrash, Shebli
    Voorhees, Peter M.
    Usmani, Saad Z.
    LEUKEMIA, 2020, 34 (01) : 1 - 20
  • [50] Extramedullary multiple myeloma
    Weinstock, Matthew
    Ghobrial, Irene M.
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1135 - 1141
12345